Short Interest in BioPharma Credit PLC (OTCMKTS:BOPCF) Decreases By 50.0%

Posted by on Jun 28th, 2024

BioPharma Credit PLC (OTCMKTS:BOPCF – Get Free Report) was the recipient of a large decline in short interest in June. As of June 15th, there was short interest totalling 100 shares, a decline of 50.0% from the May 31st total of 200 shares. Based on an average trading volume of 10,000 shares, the short-interest ratio is currently 0.0 days.

BioPharma Credit Price Performance

BOPCF opened at $0.87 on Friday. The stock’s fifty day moving average is $0.89 and its 200-day moving average is $0.90. BioPharma Credit has a one year low of $0.54 and a one year high of $1.25.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

See Also

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.